SiTime Corporation Total Cost of Revenue decreased by 5.7% to $46.61M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.5%, from $29.98M to $46.61M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 17.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.67M | $21.33M | $23.62M | $25.02M | $26.74M | $25.80M | $23.08M | $15.30M | $12.29M | $15.60M | $18.71M | $15.36M | $22.34M | $28.23M | $32.27M | $29.98M | $33.44M | $38.85M | $49.40M | $46.61M |
| QoQ Change | — | +20.7% | +10.7% | +5.9% | +6.9% | -3.5% | -10.5% | -33.7% | -19.7% | +27.0% | +19.9% | -17.9% | +45.5% | +26.4% | +14.3% | -7.1% | +11.6% | +16.2% | +27.2% | -5.7% |
| YoY Change | — | — | — | — | +51.4% | +20.9% | -2.3% | -38.8% | -54.0% | -39.5% | -18.9% | +0.4% | +81.8% | +80.9% | +72.5% | +95.2% | +49.7% | +37.6% | +53.1% | +55.5% |